^
BIOMARKER:
HIF1A overexpression
i
Other names: HIF1A, bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8, Hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
Entrez ID:
Related biomarkers:
›
HIF1A overexpression
|
HER2 Negative Breast Cancer
|
HIF1A overexpression
|
HER2 Negative Breast Cancer
|
albumin-bound paclitaxel Sensitive: B - Late Trials
|
albumin-bound paclitaxel Sensitive: B - Late Trials
|
HIF1A overexpression
|
AML
|
HIF1A overexpression
|
AML
|
azacitidine Sensitive: C3 – Early Trials
|
azacitidine Sensitive: C3 – Early Trials
|
HIF1A overexpression
|
MDS
|
HIF1A overexpression
|
MDS
|
azacitidine Sensitive: C3 – Early Trials
|
azacitidine Sensitive: C3 – Early Trials
|
HIF1A overexpression
|
SCCHN
|
HIF1A overexpression
|
SCCHN
|
nimotuzumab Sensitive: C3 – Early Trials
|
nimotuzumab Sensitive: C3 – Early Trials
|
HIF1A overexpression
|
SCCHN
|
HIF1A overexpression
|
SCCHN
|
cisplatin Resistant: C3 – Early Trials
|
cisplatin Resistant: C3 – Early Trials
|
HIF1A overexpression
|
NSCLC
|
HIF1A overexpression
|
NSCLC
|
EGFR inhibitor Resistant: D – Preclinical
|
EGFR inhibitor Resistant: D – Preclinical
|
HIF1A overexpression
|
Ovarian Cancer
|
HIF1A overexpression
|
Ovarian Cancer
|
CB-839 Sensitive: D – Preclinical
|
CB-839 Sensitive: D – Preclinical
|
HIF1A overexpression
|
Ovarian Cancer
|
HIF1A overexpression
|
Ovarian Cancer
|
olaparib + CB-839 Sensitive: D – Preclinical
|
olaparib + CB-839 Sensitive: D – Preclinical
|
HIF1A overexpression
|
HCC
|
HIF1A overexpression
|
HCC
|
sorafenib Resistant: D – Preclinical
|
sorafenib Resistant: D – Preclinical
|
